Christoph Brönnimann

Christoph Brönnimann is the CEO of Medartis Holding AG. Prior to this, they were the Area Vice President DACH at Medical Devices EMEA Johnson & Johnson from September 2015 to August 2019. Before that, they were the General Manager & Area Vice President at DePuySynthes from January 2014 to September 2015. Christoph has also held the position of VP Commercial Excellence at DePuy Synthes from July 2012 to December 2013. Christoph was also the General Manager Switzerland at Synthes from January 2005 to August 2012. Prior to that, they were a Manager at PwC in the Corporate Finance division from December 2002 to December 2004. Before that, they were a Senior Consultant / Manager at Arthur Andersen from July 2000 to November 2002. Christoph started their career as a Product Manager at Roche Vitamins Inc. from January 1995 to December 2000.

Christoph Brönnimann is a Swiss meteorologist. Christoph received their GMP from Harvard Business School in 2008 and their Dr. sc.techn. in Chemistry from Eidgenössische Technische Hochschule Zürich in 2014.

Some direct reports include Mario Della Casa - COO, Mareike Loch - VP, EMEA, and Manuel Schaer - CTO.

Links


Org chart


Teams


Offices

This person is not in any offices


Medartis Holding AG

Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.


Industries

Headquarters

Basel, Switzerland

Employees

501-1,000

Links